carbamol: RN given refers to cpd with specified locant
ID Source | ID |
---|---|
PubMed CID | 8827 |
CHEMBL ID | 3185052 |
CHEBI ID | 134755 |
SCHEMBL ID | 27834 |
MeSH ID | M0049715 |
Synonym |
---|
AKOS005444079 |
urea, bis(hydroxymethyl)- |
carbamol |
n,n'-dimethylolurea |
oxymethurea |
csi paste |
finish en |
metural |
urea,3-bis(hydroxymethyl)- |
permafresh 477 |
ureol p |
urofix |
1,3-bis(hydroxymethyl)urea |
nsc-41819 |
protesine dmu |
n,n'-dihydroxymethylurea |
nsc41819 |
caurite |
n,n'-bis(hydroxymethyl)urea |
kaurit s |
dimethanol urea |
1,3-dimethylolurea |
urea,n'-bis(hydroxymethyl)- |
dimethylolurea |
knittex asl |
methural |
140-95-4 |
1,3-bis(hydroxymethyl)harnstoff |
einecs 205-444-0 |
nsc 41819 |
papirol j 001 |
urea, 1,3-bis(hydroxymethyl)- |
urea, n,n'-bis(hydroxymethyl)- |
STK366820 |
n,n'-bis(hydroxymethyl)urea, >=95% |
CHEBI:134755 |
D0767 |
NCGC00248149-01 |
BBL000676 |
dtxsid6025141 , |
cas-140-95-4 |
dtxcid305141 |
NCGC00254620-01 |
tox21_300714 |
unii-n68h97cawg |
n68h97cawg , |
FT-0625149 |
dimethylol urea |
dihydroxymethyl carbamide |
oxymethurea [mart.] |
oxymethurea [who-dd] |
oxymethurea [mi] |
dimethylol urea [inci] |
SCHEMBL27834 |
QUBQYFYWUJJAAK-UHFFFAOYSA-N |
W-109075 |
CHEMBL3185052 |
mfcd00014414 |
VS-00664 |
H11231 |
Q27284611 |
1,3-bis-hydroxymethyl-urea |
A885715 |
CS-0064471 |
EN300-134864 |
Class | Description |
---|---|
ureas | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 11.9966 | 0.0060 | 38.0041 | 19,952.5996 | AID1159523 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (120.68) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |